What one share of Delcath Systems holds
We are an interventional oncology company focused on the treatment of cancers primary or metastatic to the liver.
Delcath Systems’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $2.40 |
|---|---|
| Profit | $0.01 |
| Capex (buildings and equipment) | $0.05 |
| Free cash flow | $0.44 |
| Cash and investments | $1.37 |
| Book value | $3.50 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2020 | — | −$8.35 | $0.27 | −$8.16 | — | — |
| 2021 | $0.50 | −$3.59 | $0.02 | −$3.18 | — | $1.51 |
| 2022 | $0.31 | −$4.12 | $0.02 | −$2.84 | — | −$0.58 |
| 2023 | $0.13 | −$2.94 | $0.00 | −$1.93 | — | $0.69 |
| 2024 | $1.30 | −$0.93 | $0.02 | −$0.67 | — | $2.08 |
| 2025 | $2.14 | $0.07 | $0.04 | $0.53 | — | $3.21 |
Common questions about Delcath Systems
How much does one share of Delcath Systems earn?
Over the last 12 months, each share of Delcath Systems earned $0.01 of profit on $2.40 of sales, keeping about 1¢ of every $1 (profit margin).
Does Delcath Systems pay a dividend?
Delcath Systems didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Delcath Systems’s book value per share?
Delcath Systems’s book value is $3.50 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Delcath Systems have?
Each share of Delcath Systems has $1.37 of cash and investments, as of June 30, 2026.
What is Delcath Systems’s free cash flow per share?
$0.44 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Delcath Systems bought back shares?
Delcath Systems’s share count rose about 1278% from 2020 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.